Novartis secures new radioligand in $900M deal as competition strengthens - Fierce Biotech

As reported by FierceBiotech

As an imposing new competitor begins to take shape, radiopharma leader Novartis has

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on FierceBiotech ↗

Market Samachar is a news aggregator. This article was originally published by FierceBiotech. Tap the button above to read the full story on their site.

INDIAN Can Moneyview IPO deliver long-term growth for high-risk investors? Markets-Economic Times
COMPANIES Sebi working towards balanced derivatives market: Tuhin Kanta Pandey Stocks-Markets-Economic Times
INDIAN Global Market Today: Asian stocks waver on inflation, rate concerns Markets-Economic Times
INDIAN AssetGro Fintech to file DRHP with Sebi for Rs 2,000-2,500 cr IPO Markets-Economic Times
INDIAN Airtel Money eyes London listing via secondary OFS Markets-Economic Times
INDIAN NSE IPO listing time today: Check share listing price prediction ahead of BSE debut - Will there be gains or discount? mint - markets
INDIAN Oil Turns Lower as Shipments From the Middle East Reclaim Focus mint - markets
INDIAN Sensex, Nifty 50 prediction today: Stock market outlook for Thursday, 24 Sept - GIFT Nifty, Nikkei, Taiwan signals mint - markets

Novartis secures new radioligand in $900M deal as competition strengthens - Fierce Biotech

More from Market Samachar